TSS:Rfhg 206420.1

Basic information about the TSS

---

TSS ID: rfhg_206420.1 Species: human Chr: chr19		Start: 5690342 End: 5690345 Strand: +
Source datasets	DRA013844
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3036856,EH38E1935204)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: BC003052:11 GeneID: 25873 HGNC/MGI_ID: HGNC:13631 UniProt_ID: Nearer transcript ids and distances:

Gene_name: RPL36 Gene_symbol: RPL36 Gene_synonyms: DKFZp566B023 L36 Gene_source: HGNC:13631

TATA-Box annotation

---

Distance to TSS:	48
Nearest PromoterID:	NM_033643
Entrez ID:	25873
Nearest Unigene:	Hs.408018
Nearest Refseq:	NM_015414
Nearest Ensembl:	ENSG00000130255
Gene Name:	RPL36
Gene Alias:	L36
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.750000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RPL36 p2@RPL36 p5@RPL36
Sample		p1@RPL36	p2@RPL36	p5@RPL36
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	745.51	431.29	30.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	775.49	453.19	32.98
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	705.64	424.00	27.97
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	773.43	445.34	34.10
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	767.58	453.98	37.79
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	693.65	406.61	33.14
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	691.13	641.23	41.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	758.39	547.17	33.67
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	814.69	609.95	37.40
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	915.81	453.27	36.52
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	819.79	472.95	37.19
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	759.44	421.60	36.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	300.46	92.69	1.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	196.66	70.06	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	258.41	89.80	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	234.39	72.43	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	245.05	74.70	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	218.50	67.49	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	219.66	70.91	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	294.26	96.88	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	260.62	87.94	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	242.88	77.85	1.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	226.20	74.06	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	241.45	84.93	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	272.44	96.49	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	313.35	92.11	1.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	258.25	96.70	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	235.05	99.02	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	240.83	93.85	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	209.92	91.03	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	246.82	93.16	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	267.67	97.10	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	249.86	89.27	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	257.80	90.55	0.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	229.81	93.31	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	238.38	99.07	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	225.43	88.50	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	224.66	89.06	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	272.53	98.59	3.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	231.42	95.78	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	235.49	100.22	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	221.06	82.13	1.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	233.67	93.00	1.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	227.28	91.61	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	219.04	86.13	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	258.70	93.52	2.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	255.50	96.92	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	267.05	100.74	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	271.21	99.34	2.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	252.54	93.01	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	392.08	141.62	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	353.80	127.42	3.11
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	167.91	27.98	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	379.70	126.33	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	378.11	111.68	2.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	471.48	52.01	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	613.09	64.75	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	390.55	119.92	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	422.02	141.64	3.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	460.49	68.52	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	674.03	109.99	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	295.54	88.60	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	512.72	35.83	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	667.64	68.29	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	561.14	103.97	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	306.70	114.30	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	242.46	48.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	331.69	47.38	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	253.51	97.50	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	244.46	99.67	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	520.25	87.72	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	605.08	104.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	262.01	125.28	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	274.56	137.89	0.61
Adipocyte - breast, donor1	11376-118A8	124.33	71.27	1.74
Adipocyte - breast, donor2	11327-117E4	125.93	82.78	2.09
Adipocyte - omental, donor1	11473-119C6	109.29	66.41	1.78
Adipocyte - omental, donor2	11474-119C7	250.41	105.40	3.74
Adipocyte - omental, donor3	11475-119C8	279.99	96.46	3.01
Adipocyte - perirenal, donor1	11476-119C9	377.05	129.51	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	233.10	78.06	3.30
Adipocyte - subcutaneous, donor2	11336-117F4	266.46	128.26	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	300.11	97.84	0.52
Adipocyte differentiation, day04, donor1	13019-139D4	127.71	54.17	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	164.47	57.91	0.77
Adipocyte differentiation, day04, donor3	13025-139E1	161.41	69.41	1.12
Adipocyte differentiation, day04, donor4	13028-139E4	192.21	58.78	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	91.69	83.33	2.57
Adipocyte differentiation, day08, donor2	13023-139D8	171.71	54.87	1.29
Adipocyte differentiation, day08, donor3	13026-139E2	142.36	48.52	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	186.41	61.21	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	136.83	88.58	2.50
Adipocyte differentiation, day12, donor2	13024-139D9	124.08	66.56	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	121.41	68.07	1.31
Adipocyte differentiation, day12, donor4	13030-139E6	78.55	56.94	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	262.32	321.33	5.30
Alveolar Epithelial Cells, donor2	11590-120G6	982.51	755.17	19.72
Alveolar Epithelial Cells, donor3	11671-122G6	357.01	161.73	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	245.03	113.88	1.62
Amniotic Epithelial Cells, donor2	11613-122A2	493.68	120.49	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	327.28	145.46	2.05
Anulus Pulposus Cell, donor1	11248-116E6	252.08	121.63	1.60
Anulus Pulposus Cell, donor2	11463-119B5	501.57	146.94	3.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	424.58	145.57	2.70
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	414.17	138.93	6.95
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	342.44	124.13	6.42
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	346.75	125.85	5.68
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	488.16	160.61	2.53
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	291.75	139.27	5.94
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	369.40	156.27	6.17
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	426.22	141.75	4.37
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	299.91	135.40	4.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	401.12	145.76	5.27
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	449.19	156.02	5.81
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	322.22	147.95	7.52
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	185.99	102.80	3.29
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	575.95	162.41	4.09
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	237.95	109.93	4.67
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	427.02	162.34	5.89
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	303.24	146.80	6.42
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	271.83	137.65	2.41
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	491.63	144.37	7.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	272.34	131.86	3.48
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	291.78	147.69	6.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	545.18	187.63	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	245.12	115.61	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	310.43	121.65	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	454.84	153.39	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	366.17	148.37	3.79
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	317.38	138.10	6.06
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	421.83	163.60	2.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	329.00	133.18	4.49
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	297.84	145.82	3.87
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	417.12	158.12	5.16
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	297.75	122.83	5.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	361.01	144.83	2.14
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	404.79	154.43	4.09
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	314.32	133.68	6.02
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	327.89	155.63	4.75
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	470.42	171.38	3.05
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	276.34	136.26	3.06
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	305.61	167.10	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	427.65	153.63	5.61
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	287.89	130.82	6.35
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	281.28	154.85	3.48
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	450.64	138.88	6.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	258.69	124.60	4.41
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	296.49	178.36	9.27
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	735.18	158.44	6.34
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	309.83	135.72	1.72
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	349.57	151.62	5.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	448.32	180.79	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	346.20	136.09	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	260.13	109.66	5.10
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	252.20	134.74	3.81
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	331.95	124.28	3.30
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	277.54	138.62	3.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	399.62	124.28	4.30
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	298.91	117.30	2.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	318.89	148.00	6.10
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	410.99	153.43	4.43
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	306.10	125.51	2.91
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	310.38	134.11	4.36
Astrocyte - cerebellum, donor1	11500-119F6	458.72	253.12	3.68
Astrocyte - cerebellum, donor2	11580-120F5	849.12	379.80	5.65
Astrocyte - cerebellum, donor3	11661-122F5	551.85	165.49	2.73
Astrocyte - cerebral cortex, donor1	11235-116D2	281.66	168.02	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	315.78	281.97	3.88
Astrocyte - cerebral cortex, donor3	11392-118C6	212.40	179.89	1.04
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	342.91	234.65	3.90
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	318.72	251.69	3.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	312.37	234.99	4.67
Basophils, donor1	12241-129G9	220.47	38.18	0.00
Basophils, donor2	12242-129H1	250.75	31.03	0.72
Basophils, donor3	12243-129H2	119.36	30.13	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	413.53	201.80	2.37
Bronchial Epithelial Cell, donor2	11591-120G7	1217.49	530.34	6.86
Bronchial Epithelial Cell, donor3	11672-122G7	451.93	157.82	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	625.77	599.41	13.18
Bronchial Epithelial Cell, donor5	11457-119A8	397.39	519.25	9.57
Bronchial Epithelial Cell, donor6	11461-119B3	343.36	324.71	4.84
Bronchial Epithelial Cell, donor7	11769-123I5	346.03	133.52	1.08
Burkitt's lymphoma cell line:DAUDI	10422-106C8	403.56	136.96	6.49
Burkitt's lymphoma cell line:RAJI	10476-106I8	544.30	306.97	11.41
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	715.98	132.39	5.12
CD133+ stem cells - cord blood derived, pool1	12223-129E9	1210.01	82.74	0.00
CD14+ Monocytes, donor1	11224-116B9	153.85	29.30	1.13
CD14+ Monocytes, donor2	11305-117B9	226.99	26.36	0.19
CD14+ Monocytes, donor3	11381-118B4	166.19	33.15	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	132.75	77.55	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	118.65	46.63	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	93.36	47.01	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	158.14	30.21	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	187.99	24.44	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	178.85	26.53	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	152.67	18.41	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	170.58	14.90	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	171.07	21.57	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	152.33	23.10	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	182.68	22.61	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	199.78	29.16	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	137.20	13.11	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	217.02	20.07	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	272.90	16.64	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	141.91	20.97	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	166.22	18.56	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	204.04	27.27	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	165.41	18.76	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	172.82	14.48	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	160.18	14.84	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	181.57	19.37	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	187.89	25.99	0.35
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	212.51	31.14	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	130.99	18.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	191.63	15.85	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	167.15	21.06	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	125.72	21.62	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	189.56	21.93	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	181.92	21.99	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	138.41	19.66	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	167.36	13.68	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	175.62	13.46	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	264.17	48.17	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	249.94	48.05	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	334.24	74.30	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	196.37	65.87	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	203.46	46.28	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	161.43	35.01	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	354.44	91.35	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	263.04	48.74	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	309.29	56.22	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	965.35	107.71	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	772.22	105.09	1.36
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	893.72	92.17	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	685.49	77.29	2.13
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	906.49	91.13	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	811.44	87.04	2.81
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	960.83	112.16	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	1077.04	122.60	1.32
CD19+ B Cells, donor1	11544-120B5	834.23	36.99	1.64
CD19+ B Cells, donor2	11624-122B4	882.85	30.47	1.45
CD19+ B Cells, donor3	11705-123B4	739.07	28.78	1.01
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	261.83	166.88	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	271.25	155.80	0.40
CD34+ Progenitors, donor1	11545-120B6	749.02	79.32	1.00
CD34+ Progenitors, donor2	11625-122B5	969.68	54.50	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	635.78	153.68	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	790.32	195.49	2.93
CD4+ T Cells, donor1	11225-116C1	595.21	47.13	3.57
CD4+ T Cells, donor2	11306-117C1	1157.98	53.28	4.90
CD4+ T Cells, donor3	11382-118B5	758.52	64.05	2.74
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	492.86	88.57	1.79
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	444.48	77.49	0.67
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	500.47	75.60	1.72
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	1605.75	91.97	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	2052.18	106.05	2.81
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	2313.95	79.11	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	304.93	69.95	1.01
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	377.39	123.88	1.53
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	377.22	133.48	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	856.25	93.69	1.79
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	821.76	75.47	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	693.85	64.68	1.76
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	552.77	67.46	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	473.92	108.46	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	679.95	140.67	1.34
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	911.80	62.54	1.09
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	1116.92	54.13	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1515.28	84.28	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	389.77	101.24	2.41
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	230.26	76.03	1.52
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	230.96	80.91	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	1222.05	128.42	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	944.05	107.45	3.03
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	831.10	61.45	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	1114.45	139.55	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1331.23	172.64	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1320.45	199.60	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	1239.81	112.43	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	1349.65	121.22	0.98
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	997.92	103.18	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	853.75	127.49	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	1056.75	182.82	1.38
CD8+ T Cells, donor1	11226-116C2	458.68	46.49	2.95
CD8+ T Cells, donor2	11307-117C2	673.15	57.07	3.00
CD8+ T Cells, donor3	11383-118B6	561.79	65.39	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	307.38	153.46	2.29
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	279.18	117.19	2.16
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	267.30	123.12	3.28
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	281.00	127.59	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	275.02	126.47	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	308.33	130.52	2.96
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	283.56	178.61	3.69
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	300.32	186.87	3.16
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	284.00	189.49	4.92
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	278.33	250.26	4.83
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	264.36	246.64	6.39
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	175.58	217.41	3.46
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	164.59	76.17	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	183.54	86.53	1.82
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	154.40	63.40	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	316.94	124.61	3.96
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	283.12	129.47	3.45
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	245.60	107.48	4.01
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	155.60	161.62	4.44
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	203.30	159.93	4.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	187.54	159.01	1.92
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	167.14	176.32	3.06
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	218.33	175.38	3.55
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	288.95	177.00	6.05
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	313.15	59.42	2.41
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	328.03	64.35	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	196.34	58.10	2.00
Cardiac Myocyte, donor1	11525-119I4	301.58	179.12	0.00
Cardiac Myocyte, donor2	11605-120I3	340.92	158.60	1.98
Cardiac Myocyte, donor3	11686-122I3	229.41	119.33	2.21
Chondrocyte - de diff, donor1	11261-116G1	265.55	90.13	5.89
Chondrocyte - de diff, donor2	11338-117F6	287.14	63.97	1.78
Chondrocyte - de diff, donor3	11410-118E6	159.86	58.25	1.48
Chondrocyte - re diff, donor2	11339-117F7	200.54	116.38	0.00
Chondrocyte - re diff, donor3	11411-118E7	186.03	76.03	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	282.76	156.76	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	343.52	219.96	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	197.35	155.14	1.95
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	111.05	50.89	0.64
Corneal Epithelial Cells, donor1	11526-119I5	373.93	225.72	1.98
Corneal Epithelial Cells, donor2	11606-120I4	645.02	255.96	5.69
Corneal Epithelial Cells, donor3	11687-122I4	428.69	334.88	7.92
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	92.62	51.34	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	98.72	60.56	1.58
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	100.07	79.37	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	73.86	54.21	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	200.54	76.19	1.02
Dendritic Cells - plasmacytoid, donor2	11309-117C4	330.35	86.18	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	383.28	93.89	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	239.98	294.68	4.84
Endothelial Cells - Aortic, donor1	11263-116G3	285.76	251.73	3.52
Endothelial Cells - Aortic, donor2	11340-117F8	304.01	167.13	1.98
Endothelial Cells - Aortic, donor3	11412-118E8	214.29	243.38	5.90
Endothelial Cells - Artery, donor1	11264-116G4	226.01	140.78	5.24
Endothelial Cells - Artery, donor2	11341-117F9	247.04	240.22	4.00
Endothelial Cells - Artery, donor3	11413-118E9	218.96	340.80	4.21
Endothelial Cells - Lymphatic, donor1	11236-116D3	180.87	91.10	3.10
Endothelial Cells - Lymphatic, donor2	11317-117D3	111.06	55.68	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	113.33	41.72	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	342.60	149.46	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	486.82	343.12	4.69
Endothelial Cells - Microvascular, donor3	11414-118F1	242.46	85.07	2.41
Endothelial Cells - Thoracic, donor1	11266-116G6	334.10	226.07	10.00
Endothelial Cells - Thoracic, donor2	11343-117G2	462.28	207.03	2.62
Endothelial Cells - Umbilical vein, donor1	11243-116E1	195.19	194.20	3.48
Endothelial Cells - Umbilical vein, donor2	11324-117E1	249.42	196.19	5.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	176.84	208.11	3.30
Endothelial Cells - Vein, donor1	11267-116G7	218.40	250.25	5.69
Endothelial Cells - Vein, donor2	11344-117G3	231.90	247.27	1.40
Endothelial Cells - Vein, donor3	11416-118F3	244.93	239.28	2.98
Eosinophils, donor1	12244-129H3	548.89	30.49	0.00
Eosinophils, donor2	12245-129H4	74.26	4.95	1.65
Eosinophils, donor3	12246-129H5	78.47	7.13	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	350.85	220.63	2.93
Esophageal Epithelial Cells, donor2	11587-120G3	1146.17	185.13	8.32
Esophageal Epithelial Cells, donor3	11668-122G3	325.38	292.84	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	199.51	77.18	1.23
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	128.43	104.01	3.28
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	266.73	152.97	4.44
Fibroblast - Aortic Adventitial, donor1	11245-116E3	171.73	158.63	6.67
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	46.54	50.08	1.23
Fibroblast - Aortic Adventitial, donor2	11326-117E3	227.60	99.88	2.64
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	91.17	31.09	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	174.40	160.12	2.33
Fibroblast - Cardiac, donor1	11268-116G8	202.77	140.17	3.63
Fibroblast - Cardiac, donor2	11345-117G4	202.37	145.53	1.52
Fibroblast - Cardiac, donor3	11417-118F4	174.28	143.99	5.36
Fibroblast - Cardiac, donor4	11452-119A3	93.05	62.74	1.21
Fibroblast - Cardiac, donor5	11456-119A7	314.09	182.74	2.54
Fibroblast - Cardiac, donor6	11460-119B2	313.04	226.03	6.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	308.31	102.10	2.68
Fibroblast - Choroid Plexus, donor2	11572-120E6	320.55	92.76	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	231.44	190.42	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	325.89	253.01	2.08
Fibroblast - Conjunctival, donor3	11692-122I9	273.23	48.51	1.02
Fibroblast - Dermal, donor1	11269-116G9	239.71	168.81	4.46
Fibroblast - Dermal, donor2	11346-117G5	354.23	408.95	5.19
Fibroblast - Dermal, donor3	11418-118F5	225.45	161.87	2.30
Fibroblast - Dermal, donor4	11450-119A1	314.61	326.93	3.39
Fibroblast - Dermal, donor5	11454-119A5	320.82	284.88	2.97
Fibroblast - Dermal, donor6	11458-119A9	270.11	280.51	2.11
Fibroblast - Gingival, donor1	11237-116D4	180.54	155.13	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	147.24	93.27	0.26
Fibroblast - Gingival, donor2	11318-117D4	276.75	228.51	2.64
Fibroblast - Gingival, donor3	11394-118C8	169.59	82.67	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	121.55	59.22	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	186.95	61.85	0.70
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	209.99	171.17	2.81
Fibroblast - Gingival, donor6 (control)	11922-125H5	226.10	156.32	1.76
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	62.46	33.88	1.06
Fibroblast - Gingival, donor7 (control)	11924-125H7	212.05	137.47	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	198.80	144.53	1.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	196.79	170.13	2.74
Fibroblast - Gingival, donor9 (control)	11927-125I1	206.02	44.32	0.00
Fibroblast - Lung, donor1	11270-116H1	216.14	222.93	0.00
Fibroblast - Lung, donor2	11347-117G6	143.25	79.08	0.00
Fibroblast - Lung, donor3	11419-118F6	197.32	221.17	1.69
Fibroblast - Lymphatic, donor1	11506-119G3	360.70	178.27	5.00
Fibroblast - Lymphatic, donor2	11586-120G2	455.95	155.25	4.20
Fibroblast - Lymphatic, donor3	11667-122G2	423.73	180.80	3.08
Fibroblast - Mammary, donor1	11540-120B1	184.31	164.01	2.03
Fibroblast - Mammary, donor2	11620-122A9	539.22	279.59	3.99
Fibroblast - Mammary, donor3	11701-123A9	351.42	113.17	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	217.83	238.01	2.13
Fibroblast - Periodontal Ligament, donor2	11319-117D5	261.50	216.30	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	83.23	84.76	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	181.65	104.56	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	237.59	160.91	1.08
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	139.98	65.41	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	166.90	221.29	7.07
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	166.82	130.04	1.02
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	404.93	258.59	4.01
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	271.22	161.31	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	67.08	39.09	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	212.79	44.05	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	244.78	66.61	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	92.36	58.97	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	253.79	98.45	1.08
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	74.91	35.94	0.25
Fibroblast - skin normal, donor1	11553-120C5	185.08	60.54	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	52.13	43.31	0.80
Fibroblast - skin normal, donor2	11561-120D4	216.90	96.14	1.31
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	94.60	51.98	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	194.03	57.50	0.17
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	504.48	53.51	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	65.03	34.81	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	192.80	111.95	1.17
Fibroblast - skin walker warburg, donor1	11554-120C6	195.00	137.47	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	154.15	47.20	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	132.96	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	611.81	101.97	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	169.72	148.05	5.89
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	110.08	116.59	3.90
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	84.32	128.52	6.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	613.21	548.14	16.08
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	589.58	615.74	20.42
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	536.58	479.81	10.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	597.57	236.05	2.21
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	326.28	168.73	2.97
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	397.85	391.11	7.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	502.77	248.74	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	342.13	159.16	2.61
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	557.20	480.25	11.06
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	314.87	216.65	3.82
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	327.31	165.13	2.22
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	235.85	189.38	4.03
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	256.96	139.63	1.98
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	266.33	173.72	1.66
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	203.51	152.07	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	226.58	110.67	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	261.71	122.07	0.87
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	186.88	94.21	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	290.16	110.80	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	295.19	113.34	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	189.24	90.71	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	235.51	117.75	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	275.50	130.96	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	131.68	98.96	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	163.99	74.19	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	179.32	65.24	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	256.83	114.08	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	141.93	92.43	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	204.39	93.31	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	249.63	107.07	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	267.60	102.61	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	177.10	108.73	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	242.47	94.12	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	300.47	112.91	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	176.36	104.39	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	328.73	108.72	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	237.36	110.58	1.14
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	177.00	97.28	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	252.39	123.16	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	231.24	114.78	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	201.11	99.90	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	206.20	99.88	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	113.05	102.12	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	128.35	102.15	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	122.56	104.20	1.22
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	152.34	127.85	1.30
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	133.37	83.49	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	145.08	78.53	0.55
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	153.30	69.96	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	85.29	26.78	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	113.31	72.02	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	135.18	72.63	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	58.97	15.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	296.40	239.47	4.78
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	276.41	213.70	1.69
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	313.83	256.75	4.91
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	423.08	379.90	20.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	428.64	407.73	19.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	416.01	350.05	7.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	623.65	264.80	17.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	497.44	343.10	16.25
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	696.34	385.07	16.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	492.09	255.61	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	476.18	302.37	6.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	422.10	276.32	7.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	366.55	199.94	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	457.50	243.57	5.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	462.48	256.25	7.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	426.13	156.02	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	540.72	255.73	2.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	510.17	283.96	4.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	628.53	273.55	10.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	808.08	331.59	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	535.14	267.86	3.26
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	493.00	198.21	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	493.32	269.23	2.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	499.84	233.35	6.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	748.13	231.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	512.81	216.42	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	492.22	223.62	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	660.81	243.46	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	688.47	253.51	3.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	507.69	203.69	1.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	606.29	149.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	873.39	257.63	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	789.97	239.59	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	757.93	210.59	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	711.53	284.77	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	753.85	231.88	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	951.44	266.78	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	890.34	281.22	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	741.71	209.35	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	585.76	204.29	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	434.55	223.84	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	559.49	216.91	3.40
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	245.38	160.92	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	164.66	93.56	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	170.92	299.10	2.25
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	413.90	82.78	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	516.33	121.56	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	210.96	333.04	4.76
Hep-2 cells mock treated, biol_rep2	11899-125E9	243.24	270.42	3.54
Hep-2 cells mock treated, biol_rep3	11900-125F1	242.75	275.51	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	207.36	328.25	4.26
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	240.27	281.75	3.65
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	225.19	262.00	4.31
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	231.02	342.48	5.36
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	253.21	275.17	3.95
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	263.99	268.15	2.56
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	427.55	197.55	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	415.48	247.13	3.03
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	169.20	140.12	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	273.36	166.84	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	584.12	219.41	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	263.48	203.51	4.02
Hepatocyte, donor1	11523-119I2	181.59	59.32	1.21
Hepatocyte, donor2	11603-120I1	220.85	101.27	0.00
Hepatocyte, donor3	11684-122I1	172.40	74.24	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	245.41	208.21	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	183.35	75.16	1.92
Iris Pigment Epithelial Cells, donor1	11530-119I9	181.66	159.30	2.47
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	362.96	534.89	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	353.79	253.66	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	297.92	325.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	261.65	373.78	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	300.32	330.35	7.51
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	320.44	522.20	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	287.05	363.93	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	374.80	342.81	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	237.15	352.48	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	325.12	415.16	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	370.32	283.18	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	164.11	365.28	5.29
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	280.49	433.48	5.54
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	392.87	330.01	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	353.35	476.81	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	296.95	505.75	6.19
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	424.41	453.68	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	312.68	458.69	3.88
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	238.27	431.46	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	465.98	370.39	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	273.80	408.25	0.81
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	190.59	358.52	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	402.43	258.70	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	280.49	425.15	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	238.21	400.70	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	467.50	211.13	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	390.85	503.66	4.25
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	259.40	396.35	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	339.08	383.30	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	347.59	446.59	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	283.31	449.74	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	591.49	279.32	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	284.40	394.09	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	317.14	455.67	1.82
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	442.52	363.50	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	275.63	368.46	1.43
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	348.42	444.65	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	271.03	291.88	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	331.50	451.88	5.86
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	300.28	386.32	3.51
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	330.03	276.60	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	244.78	400.54	2.78
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	323.11	385.08	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	314.48	262.60	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	325.23	329.59	2.62
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	344.22	373.46	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	296.19	209.07	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	305.10	316.83	4.27
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	295.10	350.52	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	202.32	222.27	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	300.98	415.11	2.76
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	674.65	314.63	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	316.64	285.60	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	475.82	277.03	2.11
Keratinocyte - epidermal, donor1	11272-116H3	180.82	130.89	4.08
Keratinocyte - epidermal, donor2	11349-117G8	216.10	232.50	5.86
Keratinocyte - epidermal, donor3	11421-118F8	177.39	177.86	2.84
Keratinocyte - oral, donor1	11251-116E9	232.71	167.55	1.25
Keratocytes, donor1	11527-119I6	483.77	351.40	2.41
Keratocytes, donor2	11607-120I5	379.66	346.85	2.34
Keratocytes, donor3	11688-122I5	366.94	126.46	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	127.48	21.98	0.00
Lens Epithelial Cells, donor1	11529-119I8	292.34	247.03	0.00
Lens Epithelial Cells, donor2	11609-120I7	236.20	84.19	0.46
Lens Epithelial Cells, donor3	11690-122I7	162.46	83.15	2.22
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	189.84	102.45	3.08
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	315.35	136.47	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	262.56	110.35	3.78
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	480.72	176.37	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	355.82	135.84	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	289.80	128.08	3.45
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	400.54	142.41	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	407.55	159.78	4.30
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	253.21	101.76	3.38
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	397.91	148.72	5.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	342.21	138.24	3.30
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	361.96	140.90	5.55
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	390.93	153.31	4.18
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	332.02	125.70	4.29
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	290.77	117.98	4.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	375.09	134.89	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	364.74	154.63	2.49
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	306.69	122.42	2.74
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	392.96	152.71	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	393.03	136.19	2.93
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	412.23	144.13	3.73
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	464.59	143.06	4.36
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	349.55	138.96	4.04
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	320.92	117.92	3.78
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	461.39	141.53	3.11
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	299.85	119.35	3.35
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	312.92	116.54	4.36
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	479.45	154.77	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	323.62	126.06	2.82
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	279.49	116.21	4.14
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	405.59	129.87	3.88
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	327.48	116.44	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	278.76	108.65	3.72
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	409.08	142.53	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	311.57	107.23	3.95
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	361.20	113.43	3.44
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	356.38	137.02	2.89
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	347.85	117.47	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	320.80	113.09	3.08
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	370.85	135.82	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	449.39	118.29	2.91
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	329.89	129.31	3.42
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	467.69	182.99	3.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	359.67	127.40	1.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	381.86	125.25	4.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	196.77	104.57	3.34
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	347.05	116.28	2.82
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	309.69	118.45	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	269.66	129.16	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	299.95	104.33	4.60
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	292.44	79.42	2.97
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	357.54	104.09	2.12
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	294.69	80.18	2.81
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	367.98	80.32	1.87
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	312.25	96.87	3.61
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	329.48	84.45	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	208.55	80.98	4.07
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	333.29	92.48	2.91
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	225.09	62.57	2.25
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	172.74	69.50	4.47
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	357.93	97.06	5.65
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	236.41	74.45	3.53
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	289.84	69.96	2.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	361.15	98.31	8.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	228.65	84.04	4.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	320.83	99.39	6.42
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	366.30	97.56	3.68
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	252.78	87.25	6.52
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	309.03	91.21	3.33
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	317.54	104.82	5.89
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	248.31	81.40	10.30
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	292.92	94.93	5.81
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	304.31	95.06	4.19
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	242.33	75.24	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	287.74	93.32	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	332.27	116.53	5.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	305.09	104.77	2.30
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	378.00	104.76	4.61
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	308.54	108.13	5.66
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	250.24	84.51	5.74
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	339.82	93.99	4.97
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	392.11	107.72	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	239.01	95.60	4.48
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	259.74	83.24	2.97
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	335.55	96.49	5.17
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	255.18	83.92	5.99
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	359.83	99.95	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	378.88	102.56	8.45
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	261.65	100.25	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	323.09	95.55	3.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	393.44	101.45	5.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	245.78	105.04	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	326.33	96.31	2.96
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	404.70	106.99	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	284.53	107.89	2.12
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	279.31	92.84	5.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	375.07	102.49	5.81
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	325.00	100.41	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	325.07	90.76	3.95
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	334.03	77.16	6.59
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	328.34	118.16	2.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	324.90	89.22	3.60
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	432.00	96.38	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	299.72	103.76	2.23
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	343.71	78.99	2.74
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	363.51	94.34	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	359.10	102.75	6.75
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	282.67	83.58	4.38
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	361.18	100.08	2.24
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	367.89	91.42	3.53
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	342.13	122.66	2.70
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	348.88	109.88	2.53
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	336.43	86.99	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	300.55	89.85	7.55
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	424.12	103.30	3.65
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	371.44	96.15	2.77
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	328.69	96.14	6.08
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	416.23	105.87	4.13
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	356.75	107.02	6.05
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	328.31	97.61	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	361.43	107.15	4.80
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	390.78	118.38	8.05
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	320.88	88.45	3.09
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	347.31	84.18	4.24
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	370.57	107.25	7.38
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	296.63	97.35	5.82
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	350.02	97.10	3.92
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	402.10	113.16	6.68
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	360.09	102.68	4.18
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	369.98	117.75	2.01
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	468.88	121.36	5.35
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	301.46	85.67	3.23
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	325.81	115.64	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	422.33	112.03	5.33
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	387.51	117.96	4.56
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	381.15	115.80	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	378.10	110.53	3.28
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	246.78	93.10	4.90
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	225.12	99.04	5.20
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	461.52	149.20	7.29
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	517.57	157.97	8.31
Macrophage - monocyte derived, donor1	11232-116C8	70.20	61.77	0.46
Macrophage - monocyte derived, donor2	11313-117C8	37.25	47.90	0.37
Macrophage - monocyte derived, donor3	11389-118C3	68.42	64.36	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	228.34	285.16	11.15
Mallassez-derived cells, donor2	11929-125I3	168.91	117.57	3.33
Mallassez-derived cells, donor3	11930-125I4	244.62	231.55	4.86
Mammary Epithelial Cell, donor1	11273-116H4	254.39	193.51	4.38
Mammary Epithelial Cell, donor2	11350-117G9	259.15	180.68	4.05
Mammary Epithelial Cell, donor3	11422-118F9	188.57	266.39	3.24
Mast cell - stimulated, donor1	11487-119E2	80.67	25.76	0.68
Mast cell, donor1	11563-120D6	129.01	36.77	0.00
Mast cell, donor2	11565-120D8	180.68	38.34	0.59
Mast cell, donor3	11566-120D9	169.74	36.25	1.13
Mast cell, donor4	11567-120E1	168.07	32.98	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	109.56	55.34	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	196.70	39.11	0.58
Mast cell, expanded, donor5	11939-126A4	135.72	67.00	0.34
Mast cell, expanded, donor8	11941-126A6	159.84	38.49	0.33
Melanocyte - dark, donor1	11502-119F8	211.93	115.22	2.98
Melanocyte - dark, donor2	11582-120F7	305.25	154.35	2.08
Melanocyte - dark, donor3	11663-122F7	103.16	96.49	0.94
Melanocyte - light, donor1	11274-116H5	78.04	58.77	1.18
Melanocyte - light, donor2	11351-117H1	118.75	108.51	0.68
Melanocyte - light, donor3	11423-118G1	113.61	119.68	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	163.06	127.76	1.77
Melanocyte, donor2 (MC+2)	12739-135I3	218.38	139.58	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	178.66	90.00	1.07
Meningeal Cells, donor1	11493-119E8	253.45	201.47	2.36
Meningeal Cells, donor2	11573-120E7	572.19	297.54	3.52
Meningeal Cells, donor3	11654-122E7	138.63	171.15	2.20
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	198.75	271.75	4.28
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	154.17	58.27	1.61
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	845.01	151.13	3.94
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	506.26	391.14	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	242.55	254.75	5.02
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	155.44	49.34	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	198.55	110.08	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	296.01	275.79	2.42
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	391.60	437.62	7.31
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	413.09	359.90	7.37
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	342.25	107.20	1.11
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	366.89	136.42	2.23
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	208.81	75.79	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	457.87	75.37	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	1036.98	149.47	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	348.38	301.63	5.76
Mesenchymal stem cells - adipose, donor0	11217-116B2	203.81	300.21	4.61
Mesenchymal stem cells - hepatic, donor0	11218-116B3	245.18	99.13	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	327.29	386.79	5.08
Mesothelial Cells, donor1	11247-116E5	98.11	83.00	3.45
Mesothelial Cells, donor2	12156-128G5	110.10	113.61	3.50
Mesothelial Cells, donor3	11402-118D7	90.84	76.38	2.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	55.36	49.96	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	132.99	88.66	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	71.85	58.89	1.77
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	27.66	38.03	3.46
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	98.56	67.57	0.62
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	69.90	45.84	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	44.00	25.48	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	111.12	63.32	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	72.15	45.15	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	19.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	111.16	56.29	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	73.65	53.85	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	34.21	17.10	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	253.09	63.72	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	101.44	58.51	2.66
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	42.11	26.32	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	112.27	57.09	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	46.96	34.07	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	87.03	42.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	36.89	21.80	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	135.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	113.16	53.69	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	55.85	36.60	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	38.70	32.07	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	76.90	48.12	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	61.21	39.12	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	49.33	32.41	0.41
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	79.59	54.06	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	53.57	34.46	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	69.43	40.30	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	41.06	29.91	2.03
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	46.40	31.48	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	69.31	38.87	0.82
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	58.23	35.58	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	38.16	22.90	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	96.11	63.91	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	59.23	42.02	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	30.17	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	97.11	58.07	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	12.23	6.12	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	105.10	55.62	3.07
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	22.07	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	28.82	21.77	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	84.04	51.07	1.24
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	46.63	45.93	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	24.31	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	75.21	45.81	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	40.26	28.88	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	45.45	24.15	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	92.30	59.48	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	40.32	39.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	26.22	24.48	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	63.05	45.85	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.10	45.08	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	7.22	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	54.49	47.10	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	79.11	49.51	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	57.21	42.42	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	69.71	61.42	1.30
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	58.77	47.19	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	27.95	17.15	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	58.98	39.23	0.53
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	69.74	52.38	0.60
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	53.82	31.92	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	87.59	63.07	2.23
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	65.23	49.75	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	29.20	29.20	0.76
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	78.41	45.74	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	76.44	59.98	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	39.10	23.46	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	71.15	45.87	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	66.60	54.78	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	48.22	28.03	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	65.21	46.16	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	271.22	173.28	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	228.13	81.98	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	120.91	60.46	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	142.01	86.26	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	116.04	58.32	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	155.53	60.54	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	187.01	61.21	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	118.26	66.05	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	104.39	57.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	181.97	67.04	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	109.93	52.77	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	90.22	45.11	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	143.23	62.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	177.74	65.69	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	165.63	70.70	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	112.16	60.72	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	133.47	77.63	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	299.46	72.48	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	243.76	85.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	143.49	55.89	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	342.61	51.39	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	388.23	55.46	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	137.82	28.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	464.32	112.94	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	163.52	104.49	3.45
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	226.81	60.62	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	108.80	121.48	6.01
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	306.77	88.90	5.84
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	152.11	83.28	3.23
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	414.92	301.62	3.19
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	96.55	73.43	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	34.92	49.62	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	170.76	89.15	3.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	210.12	126.21	7.44
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	87.01	54.05	1.35
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	198.25	89.14	2.73
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	89.08	89.08	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	156.35	105.23	3.47
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	190.01	47.37	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	126.49	68.46	2.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	130.80	61.07	1.31
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	218.34	87.85	2.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	141.10	67.37	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	143.47	67.83	1.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	342.94	38.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	113.35	56.59	1.79
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	243.58	91.72	1.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	182.84	77.36	5.63
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	304.33	61.14	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	191.52	78.09	2.25
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	152.10	24.49	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	65.74	17.70	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	212.31	90.23	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	196.88	82.14	5.08
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	188.93	45.10	1.19
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	221.06	89.71	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	108.33	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	186.27	43.65	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	224.08	105.05	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	221.02	92.85	3.17
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	169.01	70.58	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	564.91	60.92	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	171.09	49.86	2.28
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	123.76	26.58	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	257.80	108.10	1.81
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	117.29	65.26	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	222.06	67.81	3.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	220.74	63.49	0.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	110.64	40.58	1.91
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	470.00	56.86	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	198.04	67.41	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	263.61	77.93	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	40.88	30.66	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	262.77	74.38	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	92.85	28.64	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	144.37	37.83	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	158.23	68.83	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	198.39	22.67	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	60.69	30.35	0.00
Myoblast, donor1	11241-116D8	133.17	170.81	9.69
Myoblast, donor2	11322-117D8	248.94	154.39	3.84
Myoblast, donor3	11398-118D3	96.36	101.23	4.71
NK T cell leukemia cell line:KHYG-1	10777-110G3	386.58	81.28	3.65
Natural Killer Cells, donor1	11230-116C6	334.27	45.82	1.23
Natural Killer Cells, donor2	11311-117C6	513.25	55.18	1.21
Natural Killer Cells, donor3	11387-118C1	297.98	43.62	1.84
Neural stem cells, donor1	11275-116H6	148.81	117.59	1.81
Neural stem cells, donor2	11352-117H2	167.53	73.17	0.00
Neurons, donor1	11494-119E9	524.57	158.17	0.00
Neurons, donor2	11574-120E8	162.92	118.89	0.66
Neurons, donor3	11655-122E8	536.87	200.61	0.82
Neutrophils, donor1	11233-116C9	11.14	0.93	0.00
Neutrophils, donor2	11314-117C9	5.80	2.90	0.00
Neutrophils, donor3	11390-118C4	7.94	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	212.66	56.87	0.59
Nucleus Pulposus Cell, donor2	11409-118E5	342.21	96.38	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	623.92	177.69	1.80
Olfactory epithelial cells, donor1	11933-125I7	198.49	68.14	0.14
Olfactory epithelial cells, donor2	11934-125I8	211.04	96.40	1.30
Olfactory epithelial cells, donor3	11935-125I9	257.66	104.08	1.02
Olfactory epithelial cells, donor4	11936-126A1	218.17	75.19	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	157.07	147.45	3.01
Osteoblast - differentiated, donor1	11276-116H7	322.23	116.56	3.62
Osteoblast - differentiated, donor2	11353-117H3	402.38	113.17	1.14
Osteoblast - differentiated, donor3	11425-118G3	543.12	82.55	1.24
Osteoblast, donor1	11277-116H8	548.98	537.45	6.64
Osteoblast, donor2	11354-117H4	153.11	122.20	2.11
Osteoblast, donor3	11426-118G4	217.19	234.96	4.27
Pancreatic stromal cells, donor1	11249-116E7	138.15	103.02	0.76
Pericytes, donor1	11491-119E6	380.86	106.26	1.11
Pericytes, donor2	11571-120E5	732.97	215.05	3.17
Pericytes, donor3	11652-122E5	421.55	243.53	2.64
Perineurial Cells, donor1	11499-119F5	192.48	140.94	1.36
Perineurial Cells, donor2	11579-120F4	163.78	99.74	1.10
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	357.31	48.77	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	323.22	40.89	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	246.67	33.78	0.39
Placental Epithelial Cells, donor1	11278-116H9	340.57	154.50	4.78
Placental Epithelial Cells, donor2	11355-117H5	362.61	116.43	2.22
Placental Epithelial Cells, donor3	11427-118G5	258.76	93.06	2.94
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	100.95	68.67	3.16
Preadipocyte - breast, donor1	11467-119B9	145.38	57.96	2.25
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	31.59	27.67	0.52
Preadipocyte - breast, donor2	11328-117E5	201.73	83.08	3.15
Preadipocyte - omental, donor1	11468-119C1	131.49	65.21	2.34
Preadipocyte - omental, donor2	11329-117E6	82.49	59.36	1.31
Preadipocyte - omental, donor3	11403-118D8	97.55	87.67	2.58
Preadipocyte - perirenal, donor1	11469-119C2	313.00	168.31	5.91
Preadipocyte - subcutaneous, donor1	11279-116I1	164.31	291.76	4.91
Preadipocyte - subcutaneous, donor2	11356-117H6	207.00	233.74	5.31
Preadipocyte - subcutaneous, donor3	11428-118G6	177.27	175.39	4.60
Preadipocyte - visceral, donor1	11280-116I2	134.04	169.06	6.52
Preadipocyte - visceral, donor2	11357-117H7	131.61	147.26	2.76
Preadipocyte - visceral, donor3	11429-118G7	286.20	268.85	11.18
Prostate Epithelial Cells (polarized), donor1	11253-116F2	255.54	97.30	3.02
Prostate Epithelial Cells, donor2	11331-117E8	154.78	130.40	5.15
Prostate Epithelial Cells, donor3	11404-118D9	237.66	113.96	1.84
Prostate Stromal Cells, donor1	11254-116F3	148.64	166.98	2.16
Prostate Stromal Cells, donor2	11332-117E9	234.16	196.87	4.48
Prostate Stromal Cells, donor3	11405-118E1	163.61	88.43	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	323.74	196.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	154.29	126.84	0.55
Renal Epithelial Cells, donor1	11517-119H5	377.38	401.73	2.03
Renal Epithelial Cells, donor2	11597-120H4	439.60	347.84	3.56
Renal Epithelial Cells, donor3	11678-122H4	169.70	122.27	0.32
Renal Glomerular Endothelial Cells, donor1	11514-119H2	484.09	283.23	1.36
Renal Glomerular Endothelial Cells, donor2	11594-120H1	454.69	297.56	4.31
Renal Glomerular Endothelial Cells, donor3	11675-122H1	321.03	228.67	3.55
Renal Glomerular Endothelial Cells, donor4	11783-124B1	433.20	155.05	3.99
Renal Mesangial Cells, donor1	11518-119H6	287.00	202.70	1.54
Renal Mesangial Cells, donor2	11598-120H5	415.69	268.98	0.63
Renal Mesangial Cells, donor3	11679-122H5	374.51	191.69	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	241.58	260.64	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	348.74	243.74	2.95
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	275.00	271.34	2.70
Retinal Pigment Epithelial Cells, donor0	11215-116A9	215.72	248.13	3.11
Retinal Pigment Epithelial Cells, donor1	11528-119I7	316.93	153.78	1.99
Retinal Pigment Epithelial Cells, donor2	11608-120I6	371.51	358.13	5.15
Retinal Pigment Epithelial Cells, donor3	11689-122I6	317.15	92.08	1.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	135.77	47.57	0.80
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	678.09	174.21	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	362.69	132.09	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	678.66	176.92	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	194.52	140.69	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	190.17	191.76	3.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	128.38	163.63	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	170.31	176.39	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	200.46	211.41	2.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	237.14	224.66	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	202.49	156.49	2.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	174.57	183.34	3.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	152.49	188.15	3.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	218.20	169.14	2.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	168.48	186.30	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	236.09	238.53	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	193.47	138.41	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	162.57	186.23	3.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	93.20	118.19	2.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	227.86	154.34	3.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	135.30	179.79	2.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	199.17	200.89	3.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	205.26	159.02	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	164.82	165.94	2.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	187.99	193.46	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	221.90	154.25	2.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	160.53	169.48	2.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	192.35	233.58	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	242.24	179.03	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	171.83	180.95	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	235.95	235.25	4.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	231.82	177.91	2.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	217.67	187.36	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	229.35	231.03	5.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	207.93	166.08	2.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	153.27	172.17	3.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	191.64	204.56	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	200.82	157.32	3.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	153.77	168.17	3.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	197.82	216.38	3.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	189.69	134.30	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	157.28	196.78	3.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	162.06	160.20	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	245.15	125.96	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	206.43	202.86	2.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	194.69	149.75	2.02
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	255.59	127.79	2.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	339.23	148.13	3.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	240.26	118.47	2.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	288.47	150.54	2.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	119.64	83.40	1.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	284.14	145.41	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	382.78	165.17	3.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	232.30	116.71	2.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	158.46	95.55	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	234.26	90.56	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	242.90	151.76	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	143.03	81.73	3.00
Schwann Cells, donor1	11498-119F4	859.30	490.49	2.82
Schwann Cells, donor2	11578-120F3	313.02	248.38	0.00
Schwann Cells, donor3	11659-122F3	283.27	178.55	2.85
Sebocyte, donor1	11220-116B5	121.06	146.80	3.83
Sebocyte, donor2	11301-117B5	239.89	183.36	4.14
Sebocyte, donor3	11378-118B1	233.73	129.03	4.12
Sertoli Cells, donor1	11255-116F4	180.57	120.93	3.31
Sertoli Cells, donor2	11333-117F1	324.80	90.38	0.00
Skeletal Muscle Cells, donor1	11281-116I3	300.18	135.40	3.26
Skeletal Muscle Cells, donor2	11358-117H8	390.34	149.63	0.72
Skeletal Muscle Cells, donor3	11430-118G8	441.43	512.49	8.36
Skeletal Muscle Cells, donor4	11451-119A2	449.60	445.68	10.68
Skeletal Muscle Cells, donor5	11455-119A6	379.94	383.50	6.54
Skeletal Muscle Cells, donor6	11459-119B1	299.34	358.75	4.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	254.41	186.24	1.64
Skeletal Muscle Satellite Cells, donor2	11321-117D7	394.53	250.13	2.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	195.74	307.15	5.06
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	218.80	106.92	2.78
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	437.88	441.50	5.79
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	410.04	270.24	6.05
Skin - palm, donor1	10286-104F7	1093.25	64.47	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	159.29	112.15	4.18
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	94.06	52.35	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	174.10	126.84	3.51
Small Airway Epithelial Cells, donor1	11256-116F5	225.19	163.47	5.70
Small Airway Epithelial Cells, donor2	11334-117F2	242.21	122.93	5.20
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	85.21	64.70	1.48
Small Airway Epithelial Cells, donor3	11406-118E2	177.11	106.80	2.32
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	510.40	104.92	4.63
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	96.49	23.79	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	213.97	203.98	4.70
Smooth Muscle Cells - Aortic, donor1	11283-116I5	167.29	118.01	4.20
Smooth Muscle Cells - Aortic, donor2	11360-117I1	301.64	315.81	11.03
Smooth Muscle Cells - Aortic, donor3	11432-118H1	286.62	179.24	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	376.28	72.05	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	230.09	228.10	5.72
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	260.44	157.82	5.98
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	391.00	291.53	10.37
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	200.89	169.63	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	142.94	119.61	3.54
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	150.34	137.38	1.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	358.21	299.48	3.25
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	426.21	94.98	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	237.16	191.44	3.03
Smooth Muscle Cells - Carotid, donor2	11362-117I3	348.88	287.67	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	370.03	390.53	4.29
Smooth Muscle Cells - Colonic, donor1	11239-116D6	204.69	157.35	1.33
Smooth Muscle Cells - Colonic, donor2	11320-117D6	330.18	192.42	1.94
Smooth Muscle Cells - Colonic, donor3	11396-118D1	182.42	204.14	3.04
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	275.17	316.01	9.74
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	440.85	560.50	14.01
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	285.41	287.50	8.37
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	440.75	377.25	2.73
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	238.89	73.27	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	131.94	105.37	3.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	274.20	127.20	4.32
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	574.22	328.47	10.87
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	179.09	325.06	5.30
Smooth Muscle Cells - Prostate, donor1	11257-116F6	225.57	122.37	1.86
Smooth Muscle Cells - Prostate, donor2	11335-117F3	235.29	128.85	2.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	146.87	46.67	1.52
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	175.50	194.80	4.98
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	384.84	202.55	3.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	236.48	129.22	2.58
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	143.71	185.10	2.33
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	249.92	224.17	8.58
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	386.10	308.07	7.52
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	264.91	181.42	2.65
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	228.18	269.33	3.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	295.71	102.31	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	205.08	234.73	5.04
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	269.49	360.00	4.08
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	441.88	422.32	6.77
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	202.91	171.47	1.26
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	272.06	131.55	0.92
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	621.42	224.28	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	198.67	274.27	3.67
Smooth Muscle Cells - Uterine, donor1	11258-116F7	287.45	129.48	3.09
Smooth Muscle Cells - Uterine, donor3	11466-119B8	180.52	212.70	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	246.84	49.76	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	223.20	104.72	3.17
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	313.92	91.87	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	286.03	107.08	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	215.20	162.67	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	394.26	189.06	3.15
Smooth muscle cells - airway, control, donor1	11966-126D4	277.57	79.49	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	284.71	58.30	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	395.43	96.14	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	480.36	81.59	0.00
Synoviocyte, donor1	11291-117A4	150.98	71.54	0.84
Synoviocyte, donor2	11368-117I9	178.52	65.21	2.01
Synoviocyte, donor3	11440-118H9	350.31	64.79	2.01
Trabecular Meshwork Cells, donor1	11532-120A2	308.73	310.16	3.57
Trabecular Meshwork Cells, donor2	11612-122A1	465.78	342.89	5.95
Trabecular Meshwork Cells, donor3	11693-123A1	366.31	251.92	3.24
Tracheal Epithelial Cells, donor1	11292-117A5	227.24	275.70	3.01
Tracheal Epithelial Cells, donor2	11369-118A1	228.85	447.25	6.19
Tracheal Epithelial Cells, donor3	11441-118I1	330.43	392.85	2.86
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	123.52	47.24	0.49
Urethra, donor2	10319-105A4	206.82	52.15	1.80
Urothelial Cells, donor1	11520-119H8	300.20	202.17	3.45
Urothelial Cells, donor2	11600-120H7	393.35	231.53	2.00
Urothelial Cells, donor3	11681-122H7	356.87	170.30	1.60
Urothelial cells, donor0	11216-116B1	186.12	122.37	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	396.84	48.05	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	521.81	58.61	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	340.21	52.02	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	264.45	43.04	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	368.95	41.83	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	402.96	35.40	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	480.92	42.22	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	353.29	45.64	0.00
Wilms' tumor cell line:G-401	10809-111A8	280.65	117.93	4.07
Wilms' tumor cell line:HFWT	10597-108E3	402.18	144.33	2.64
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	268.70	205.02	0.84
achilles tendon, donor2	10292-104G4	214.92	45.46	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	330.17	211.10	11.22
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	328.06	211.28	16.25
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	208.33	105.29	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	337.15	244.09	28.03
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	325.21	239.76	2.81
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	373.90	142.75	5.71
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	693.32	72.14	4.36
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	1107.33	246.76	9.69
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	542.30	164.16	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	556.43	199.59	9.71
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	463.13	434.06	9.94
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	928.32	202.83	11.70
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	641.14	313.72	20.68
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	742.27	451.27	13.20
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	490.97	262.14	8.77
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	428.04	130.60	4.18
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	433.46	166.15	2.06
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	228.37	139.97	11.36
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	206.95	211.22	8.11
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	214.43	158.62	4.55
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	224.58	195.21	7.94
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	346.36	315.40	6.01
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	478.31	278.18	5.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	289.88	228.56	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	276.09	211.68	4.14
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	370.71	187.97	5.23
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	294.29	138.71	7.50
adenocarcinoma cell line:IM95m	10796-110I4	312.98	106.92	3.06
adipose tissue, adult, pool1	10010-101C1	111.22	27.61	1.09
adipose, donor1	10184-103D4	565.30	163.02	0.59
adipose, donor2	10185-103D5	640.72	120.03	0.81
adipose, donor3	10186-103D6	307.96	137.23	1.09
adipose, donor4	10187-103D7	260.89	204.55	2.60
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	357.30	188.28	6.15
adrenal gland, adult, pool1	10081-102A9	236.45	98.22	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	439.71	197.57	1.47
alveolar cell carcinoma cell line:SW 1573	10708-109H6	581.33	326.57	3.57
amniotic membrane cells, donor1	12235-129G3	109.66	39.65	0.93
amniotic membrane cells, donor2	12236-129G4	132.20	49.70	0.00
amniotic membrane cells, donor3	12237-129G5	227.73	39.48	0.29
amygdala - adult, donor10196	10167-103B5	118.58	69.96	0.00
amygdala, adult, donor10252	10151-102I7	123.49	55.56	0.61
amygdala, newborn, donor10223	10360-105E9	141.37	56.81	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	190.61	38.45	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	903.23	613.77	26.70
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	679.77	70.48	7.01
aorta, adult, pool1	10052-101G7	142.39	37.27	0.78
appendix, adult	10189-103D9	317.48	83.06	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	442.30	179.88	12.04
artery, adult	10190-103E1	199.73	66.58	1.36
astrocytoma cell line:TM-31	10425-106D2	164.57	74.17	1.01
b cell line:RPMI1788	10427-106D4	364.32	124.02	3.27
basal cell carcinoma cell line:TE 354.T	10702-109G9	112.37	92.94	1.66
bile duct carcinoma cell line:HuCCT1	10432-106D9	181.10	157.48	3.97
bile duct carcinoma cell line:TFK-1	10496-107C1	244.71	62.60	4.18
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	1110.65	188.46	2.24
bladder, adult, pool1	10011-101C2	139.06	31.51	0.33
blood, adult, pool1	10053-101G8	230.32	53.15	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	99.34	76.21	0.00
bone marrow, adult	10192-103E3	139.01	72.21	0.00
brain, adult, donor1	10084-102B3	85.08	56.38	2.05
brain, adult, pool1	10012-101C3	66.15	35.19	0.22
brain, fetal, pool1	10085-102B4	379.34	96.17	0.00
breast carcinoma cell line:MCF7	10482-107A5	391.48	85.89	3.63
breast carcinoma cell line:MDA-MB-453	10419-106C5	181.12	63.53	1.25
breast, adult, donor1	10080-102A8	207.72	52.40	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	312.13	174.80	2.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	215.22	156.47	2.16
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	239.43	185.10	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	191.97	98.29	1.45
carcinoid cell line:NCI-H1770	10703-109H1	561.38	279.28	1.88
carcinoid cell line:NCI-H727	10735-110B6	213.73	108.83	2.41
carcinoid cell line:SK-PN-DW	10719-109I8	720.30	461.72	5.39
carcinosarcoma cell line:JHUCS-1	10642-109A3	622.32	116.32	2.66
caudate nucleus - adult, donor10196	10177-103C6	108.22	35.69	0.00
caudate nucleus, adult, donor10252	10164-103B2	99.56	51.87	0.67
caudate nucleus, adult, donor10258	10379-105H1	162.00	62.66	1.53
caudate nucleus, newborn, donor10223	10354-105E3	187.15	53.84	0.37
cerebellum - adult, donor10196	10173-103C2	145.66	52.44	0.00
cerebellum, adult, donor10252	10166-103B4	93.09	40.57	0.85
cerebellum, adult, pool1	10083-102B2	187.65	65.88	3.45
cerebellum, newborn, donor10223	10357-105E6	187.64	57.29	3.32
cerebral meninges, adult	10188-103D8	143.22	72.36	1.01
cerebrospinal fluid, donor2	10294-104G6	203.92	76.01	0.73
cervical cancer cell line:D98-AH2	10552-107I3	271.32	222.43	3.74
cervical cancer cell line:ME-180	10553-107I4	212.12	96.61	2.15
cervix, adult, pool1	10013-101C4	187.72	41.47	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	162.89	89.59	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	181.57	77.07	1.31
choriocarcinoma cell line:BeWo	10423-106C9	337.16	196.23	2.36
choriocarcinoma cell line:SCH	10785-110H2	225.23	59.63	1.60
choriocarcinoma cell line:T3M-3	10618-108G6	336.32	94.16	1.66
chorionic membrane cells, donor1	12238-129G6	115.96	44.73	1.14
chorionic membrane cells, donor2	12239-129G7	104.80	89.69	0.50
chorionic membrane cells, donor3	12240-129G8	217.05	43.96	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	623.05	268.61	33.32
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	339.82	212.27	4.99
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	582.45	281.51	8.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	314.84	346.42	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	323.39	329.44	1.94
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	253.70	254.92	2.85
chronic myelogenous leukemia cell line:K562	10454-106G4	349.22	636.02	6.18
chronic myelogenous leukemia cell line:KU812	10409-106B4	379.99	199.64	6.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	202.75	146.52	0.46
clear cell carcinoma cell line:TEN	10636-108I6	398.20	149.74	2.78
colon carcinoma cell line:CACO-2	10513-107D9	182.49	194.02	2.93
colon carcinoma cell line:COLO-320	10420-106C6	312.05	136.45	1.90
colon, adult, donor1	10082-102B1	214.21	85.68	0.00
colon, adult, pool1	10014-101C5	216.32	58.05	0.94
colon, fetal, donor1	10070-101I7	502.42	63.03	0.62
common myeloid progenitor CMP, donor1	12130-128D6	284.18	87.09	0.00
common myeloid progenitor CMP, donor2	12134-128E1	1351.98	250.37	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	235.84	154.68	4.67
cord blood derived cell line:COBL-a 24h infection	10453-106G3	213.12	238.47	4.38
cord blood derived cell line:COBL-a untreated	10449-106F8	217.44	263.83	4.65
corpus callosum, adult, pool1	10042-101F6	61.03	32.28	0.22
cruciate ligament, donor2	10295-104G7	235.04	63.22	0.00
diaphragm, fetal, donor1	10069-101I6	294.54	62.60	2.41
diencephalon, adult	10193-103E4	101.04	53.04	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	592.63	297.58	9.64
ductal cell carcinoma cell line:KLM-1	10438-106E6	185.92	107.45	1.28
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	382.27	117.95	2.89
ductus deferens, adult	10196-103E7	171.93	55.81	2.49
duodenum, fetal, donor1, tech_rep1	10071-101I8	534.33	70.57	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	414.91	66.94	2.94
dura mater, adult, donor1	10041-101F5	100.34	34.69	1.32
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	742.39	534.31	62.85
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	625.62	667.60	40.84
embryonic pancreas cell line:1B2C6	10604-108F1	297.21	117.16	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	455.88	159.83	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	318.94	136.78	1.85
embryonic pancreas cell line:2C6	10603-108E9	407.17	137.91	5.25
endometrial carcinoma cell line:OMC-2	10497-107C2	205.81	147.15	3.35
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	347.07	123.78	4.53
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	328.54	132.67	6.91
epidermoid carcinoma cell line:A431	10426-106D3	159.51	107.49	1.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	148.70	158.16	2.42
epididymis, adult	10197-103E8	196.12	58.61	2.30
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	194.44	100.77	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	301.22	134.49	3.54
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	152.15	241.79	3.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	145.56	169.97	4.04
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	169.61	243.44	4.15
esophagus, adult, pool1	10015-101C6	182.10	54.15	2.02
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	472.64	78.65	4.76
eye - muscle inferior rectus, donor1	10272-104E2	248.70	41.05	2.41
eye - muscle lateral, donor2	10298-104H1	202.00	46.29	2.10
eye - muscle medial, donor2	10299-104H2	148.82	46.13	0.00
eye - muscle superior, donor2	10297-104G9	191.46	72.23	1.15
eye - vitreous humor, donor1	10268-104D7	259.42	93.27	2.91
eye, fetal, donor1	10054-101G9	173.64	50.34	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	299.40	238.24	5.26
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	484.34	341.88	11.16
frontal lobe, adult, pool1	10040-101F4	45.60	34.34	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	124.60	130.31	2.40
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	113.38	73.15	0.64
gall bladder, adult	10198-103E9	184.21	62.05	1.93
gamma delta positive T cells, donor1	11937-126A2	484.78	88.04	0.54
gamma delta positive T cells, donor2	11938-126A3	295.81	70.59	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	165.59	104.55	1.48
gastric adenocarcinoma cell line:MKN45	10612-108F9	1201.11	308.50	4.64
gastric cancer cell line:AZ521	10549-107H9	284.95	222.65	5.90
gastric cancer cell line:GSS	10560-108A2	479.58	181.21	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	320.30	60.54	5.71
giant cell carcinoma cell line:LU65	10487-107B1	347.66	240.84	3.67
giant cell carcinoma cell line:Lu99B	10433-106E1	161.65	113.37	0.70
glassy cell carcinoma cell line:HOKUG	10688-109F4	159.13	76.82	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	131.31	115.79	2.85
glioblastoma cell line:A172, tech_rep2	10444-106F3	137.21	122.32	2.95
glioblastoma cell line:T98G	10485-107A8	150.33	126.27	1.66
glioma cell line:GI-1	10413-106B8	121.25	36.32	1.46
globus pallidus - adult, donor10196	10175-103C4	134.85	38.63	1.46
globus pallidus, adult, donor10252	10161-103A8	121.56	41.74	0.24
globus pallidus, adult, donor10258	10367-105F7	421.72	87.63	0.00
globus pallidus, newborn, donor10223	10364-105F4	200.91	57.02	1.07
granulocyte macrophage progenitor, donor1	12131-128D7	188.43	53.84	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	754.06	207.64	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	1311.87	240.42	5.23
granulosa cell tumor cell line:KGN	10624-108H3	222.08	104.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	393.46	285.11	3.21
hIPS +CCl2, biol_rep2	14384-156C1	470.07	299.05	2.74
hIPS +CCl2, biol_rep3	14385-156C2	454.73	369.07	4.51
hIPS, biol_rep1	14380-156B6	166.73	238.59	0.00
hIPS, biol_rep2	14381-156B7	305.90	320.99	0.69
hIPS, biol_rep3	14382-156B8	134.62	86.07	0.00
hairy cell leukemia cell line:Mo	10712-109I1	442.22	197.69	6.61
heart - mitral valve, adult	10205-103F7	116.30	60.09	1.49
heart - pulmonic valve, adult	10206-103F8	96.48	58.31	0.52
heart - tricuspid valve, adult	10207-103F9	172.36	97.42	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	98.76	78.97	1.63
heart, adult, diseased, donor1	10051-101G6	115.83	101.77	0.43
heart, adult, pool1	10016-101C7	101.42	95.44	1.15
heart, fetal, pool1	10046-101G1	117.47	54.83	0.62
hepatic mesenchymal tumor cell line:LI90	10778-110G4	153.64	94.41	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	394.81	60.65	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	182.21	150.50	4.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	170.77	164.10	4.01
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	164.21	140.46	4.04
hepatoma cell line:Li-7	10484-107A7	19.24	63.06	3.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	298.69	296.07	10.25
hippocampus - adult, donor10196	10169-103B7	109.77	63.40	0.95
hippocampus, adult, donor10252	10153-102I9	111.64	51.23	0.41
hippocampus, adult, donor10258	10374-105G5	93.12	56.27	1.00
hippocampus, newborn, donor10223	10363-105F3	130.77	67.68	2.47
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	649.41	551.75	6.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	482.05	447.10	9.23
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	437.21	410.30	8.63
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	619.69	237.39	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	525.20	235.75	1.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	626.74	249.02	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	373.70	162.62	1.17
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	345.12	146.71	3.02
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	359.52	163.91	3.34
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	301.67	148.47	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	332.20	178.88	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	298.27	142.74	2.02
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	320.48	371.02	6.73
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	422.02	395.00	9.33
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	665.04	484.38	6.98
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	406.07	190.91	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	440.43	176.17	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	578.72	183.91	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	460.99	129.80	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	517.47	122.77	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	584.50	133.44	1.25
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	304.56	134.07	1.14
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	311.50	131.22	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	386.21	144.08	1.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	415.68	424.36	4.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	403.96	429.92	7.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	530.80	540.60	8.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	368.28	208.78	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	379.45	210.32	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	414.59	232.72	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	387.84	131.87	1.55
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	484.84	136.82	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	421.23	146.74	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	295.53	144.19	2.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	512.64	196.12	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	368.32	176.43	3.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	418.53	420.70	7.73
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	599.86	532.12	8.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	478.54	445.86	10.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	423.59	163.81	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	771.02	312.31	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	522.23	244.57	1.32
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	499.14	147.22	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	473.71	129.55	3.26
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	450.89	148.04	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	421.26	136.05	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	215.60	101.98	0.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	358.30	173.22	1.89
immature langerhans cells, donor1	11904-125F5	226.89	42.86	1.45
immature langerhans cells, donor2	11905-125F6	327.15	57.03	1.58
insula, adult, pool1	10039-101F3	53.94	48.26	1.14
keratoacanthoma cell line:HKA-1	10791-110H8	266.95	97.54	4.55
kidney, adult, pool1	10017-101C8	84.01	51.17	1.00
kidney, fetal, pool1	10045-101F9	125.06	46.33	0.64
large cell lung carcinoma cell line:IA-LM	10509-107D5	346.67	140.88	6.82
large cell lung carcinoma cell line:NCI-H460	10839-111E2	491.17	100.92	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	457.10	108.26	2.02
left atrium, adult, donor1	10079-102A7	213.58	46.31	0.00
left ventricle, adult, donor1	10078-102A6	182.54	59.16	0.00
leiomyoblastoma cell line:G-402	10721-110A1	362.53	295.77	4.10
leiomyoma cell line:10964C	10569-108B2	284.17	164.18	3.59
leiomyoma cell line:15242A	10570-108B3	191.31	145.65	3.26
leiomyoma cell line:15425	10571-108B4	187.45	130.15	3.64
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	82.54	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	202.84	71.10	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	1066.65	596.43	17.94
liposarcoma cell line:KMLS-1	10782-110G8	196.98	76.23	3.28
liposarcoma cell line:SW 872	10726-110A6	149.25	126.71	1.58
liver, adult, pool1	10018-101C9	107.77	64.01	2.43
liver, fetal, pool1	10086-102B5	126.06	76.20	0.00
locus coeruleus - adult, donor10196	10182-103D2	83.41	57.75	0.44
locus coeruleus, adult, donor10252	10165-103B3	93.01	47.06	1.66
locus coeruleus, adult, donor10258	10375-105G6	163.92	55.86	1.69
locus coeruleus, newborn, donor10223	10362-105F2	97.16	60.57	1.26
lung adenocarcinoma cell line:A549	10499-107C4	118.19	53.70	1.38
lung adenocarcinoma cell line:PC-14	10408-106B3	133.74	69.63	2.07
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	135.77	116.92	4.22
lung, adult, pool1	10019-101D1	126.40	34.02	0.59
lung, fetal, donor1	10068-101I5	278.56	45.67	1.14
lung, right lower lobe, adult, donor1	10075-102A3	231.40	40.78	0.92
lymph node, adult, donor1	10077-102A5	548.15	65.32	0.95
lymphangiectasia cell line:DS-1	10727-110A7	405.26	177.53	3.95
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	192.73	105.80	6.94
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	103.64	31.43	1.70
mature adipocyte, donor1	12231-129F8	72.81	44.40	0.89
mature adipocyte, donor2	12232-129F9	81.14	42.34	0.21
mature adipocyte, donor3	12233-129G1	59.27	47.41	0.47
mature adipocyte, donor4	12234-129G2	120.82	54.49	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	287.58	107.93	3.34
medial frontal gyrus - adult, donor10196	10170-103B8	102.65	59.79	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	81.29	44.87	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	144.87	54.96	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	172.30	63.12	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	124.88	84.21	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	89.98	45.63	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	86.68	38.53	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	57.41	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	175.52	63.17	1.79
medulla oblongata - adult, donor10196	10174-103C3	102.54	41.53	0.00
medulla oblongata, adult, donor10252	10155-103A2	77.09	40.40	0.77
medulla oblongata, adult, pool1	10038-101F2	43.26	28.81	0.98
medulla oblongata, newborn, donor10223	10361-105F1	130.19	58.67	1.04
medulloblastoma cell line:D283 Med	10838-111E1	790.22	216.10	1.55
medulloblastoma cell line:ONS-76	10759-110E3	173.99	172.04	3.91
melanoma cell line:COLO 679	10514-107E1	116.15	107.67	1.29
melanoma cell line:G-361	10465-106H6	245.95	134.37	1.36
meningioma cell line:HKBMM	10691-109F7	507.26	149.07	1.81
merkel cell carcinoma cell line:MKL-1	10843-111E6	328.67	198.26	7.93
merkel cell carcinoma cell line:MS-1	10844-111E7	227.60	273.22	7.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	235.83	169.39	5.98
mesenchymal precursor cell - adipose, donor2	11748-123G2	272.49	86.16	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	166.47	128.79	5.38
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	187.25	78.67	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	210.67	77.03	0.96
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	261.67	110.36	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	218.49	68.65	1.89
mesenchymal precursor cell - cardiac, donor2	11753-123G7	230.84	84.08	2.19
mesenchymal precursor cell - cardiac, donor3	11754-123G8	209.70	172.96	2.65
mesenchymal precursor cell - cardiac, donor4	11755-123G9	179.74	139.09	5.40
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	136.57	127.61	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	213.42	51.38	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	196.63	136.71	2.21
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	255.53	189.55	3.84
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	207.23	105.76	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	198.06	78.72	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	191.69	96.00	0.62
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	128.36	108.30	4.33
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	125.03	124.61	3.78
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	164.83	110.88	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	178.74	98.12	1.58
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	184.82	55.59	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	184.00	95.58	1.43
mesenchymal stem cell line:Hu5/E18	10568-108B1	208.40	191.98	1.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	217.38	97.73	3.65
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	205.65	71.11	2.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	218.04	81.41	4.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	199.64	77.33	2.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	185.93	69.90	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	239.29	74.12	2.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	218.89	75.84	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	222.89	65.80	3.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	96.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	212.85	89.99	2.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	198.34	72.73	2.23
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	197.33	66.58	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	183.33	71.13	2.93
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	208.11	67.47	3.69
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	225.98	72.87	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	226.38	68.73	3.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	385.55	123.05	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	284.07	92.97	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	304.97	119.20	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	320.10	120.76	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	423.27	141.80	3.73
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	382.72	101.40	3.27
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	325.75	110.79	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	304.32	104.94	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	389.44	118.22	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	252.66	95.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	282.84	106.73	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	318.02	129.16	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	432.84	54.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	396.50	116.54	4.43
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	369.74	88.64	2.76
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	358.92	81.67	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	419.14	59.88	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	389.16	75.77	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	340.24	66.01	2.85
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	333.67	69.12	3.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	344.87	59.54	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	329.16	64.83	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	359.57	69.51	5.35
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	384.37	119.45	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	344.11	79.61	7.70
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	318.04	110.83	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	254.83	131.12	5.94
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	231.03	133.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	244.25	129.12	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	177.31	149.10	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	213.70	143.92	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	195.13	134.31	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	171.75	74.65	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	162.68	99.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	173.80	87.31	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	171.04	67.46	1.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	209.62	86.96	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	198.63	72.32	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	147.78	55.71	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	183.32	190.65	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	188.35	134.37	3.71
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	269.24	222.23	17.09
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	239.51	236.63	9.04
mesothelioma cell line:Mero-25	10850-111F4	227.18	98.04	3.18
mesothelioma cell line:Mero-41	10851-111F5	287.99	154.26	0.98
mesothelioma cell line:Mero-48a	10852-111F6	208.59	128.87	3.54
mesothelioma cell line:Mero-82	10853-111F7	362.15	154.79	6.31
mesothelioma cell line:Mero-83	10854-111F8	245.46	131.24	5.28
mesothelioma cell line:Mero-84	10855-111F9	295.49	140.29	1.77
mesothelioma cell line:Mero-95	10856-111G1	209.32	100.21	2.48
mesothelioma cell line:NCI-H2052	10847-111F1	283.26	136.00	2.82
mesothelioma cell line:NCI-H226	10846-111E9	358.73	203.98	10.32
mesothelioma cell line:NCI-H2452	10848-111F2	296.38	174.07	3.93
mesothelioma cell line:NCI-H28	10845-111E8	330.04	122.91	2.54
mesothelioma cell line:No36	10857-111G2	256.07	147.44	0.65
mesothelioma cell line:ONE58	10858-111G3	180.45	105.94	1.35
migratory langerhans cells, donor1	11901-125F2	165.05	63.53	0.00
migratory langerhans cells, donor2	11902-125F3	103.19	41.03	0.00
migratory langerhans cells, donor3	11903-125F4	283.22	59.05	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	303.30	186.09	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	102.79	229.95	1.70
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	344.15	152.73	7.60
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	286.77	144.43	2.47
myelodysplastic syndrome cell line:SKM-1	10772-110F7	453.30	225.26	7.02
myeloma cell line:PCM6	10474-106I6	696.18	92.51	6.33
myxofibrosarcoma cell line:MFH-ino	10600-108E6	163.85	140.01	2.03
myxofibrosarcoma cell line:NMFH-1	10684-109E9	258.32	120.43	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	458.85	170.93	2.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	400.06	169.81	1.91
nasal epithelial cells, donor2	12227-129F4	193.75	72.86	1.10
neuroblastoma cell line:CHP-134	10508-107D4	537.42	145.40	3.22
neuroblastoma cell line:NB-1	10539-107G8	228.99	295.59	4.49
neuroblastoma cell line:NBsusSR	10607-108F4	355.35	180.31	4.43
neuroblastoma cell line:NH-12	10555-107I6	931.94	129.89	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	440.05	80.18	2.37
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	373.30	112.29	3.96
neuroectodermal tumor cell line:TASK1	10774-110F9	1017.77	327.25	6.24
neuroepithelioma cell line:SK-N-MC	10728-110A8	501.62	268.93	4.45
neurofibroma cell line:Hs 53.T	10729-110A9	233.16	129.09	2.93
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	39.84	0.00
neutrophil PMN, donor3	12141-128E8	85.24	56.82	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	255.20	71.54	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	176.91	276.98	6.40
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	234.36	90.41	2.24
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	234.65	111.67	1.84
nucleus accumbens, adult, pool1	10037-101F1	47.99	39.46	1.12
occipital cortex - adult, donor10196	10172-103C1	92.72	43.27	2.06
occipital cortex, adult, donor10252	10163-103B1	115.66	33.55	0.00
occipital cortex, newborn, donor10223	10355-105E4	135.02	57.50	0.73
occipital lobe, adult, donor1	10076-102A4	167.94	76.36	0.79
occipital lobe, fetal, donor1	10073-102A1	610.18	118.86	0.43
occipital pole, adult, pool1	10036-101E9	45.02	38.24	0.79
olfactory region, adult	10195-103E6	107.18	52.92	0.38
optic nerve, donor1	10277-104E7	228.12	58.03	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	177.81	64.13	4.90
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	232.18	188.91	0.41
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	165.60	95.16	2.03
oral squamous cell carcinoma cell line:SAS	10544-107H4	353.46	115.62	3.00
osteoclastoma cell line:Hs 706.T	10704-109H2	146.98	60.85	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	450.35	182.20	3.74
osteosarcoma cell line:HS-Os-1	10558-107I9	282.89	160.32	1.91
ovary, adult, pool1	10020-101D2	284.42	31.80	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	253.90	170.85	6.60
pancreas, adult, donor1	10049-101G4	602.95	87.48	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	440.55	118.80	3.07
papillary adenocarcinoma cell line:8505C	10437-106E5	175.97	101.70	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	155.48	26.49	0.33
paracentral gyrus, adult, pool1	10035-101E8	41.46	39.26	0.55
parietal cortex, adult, donor10258	10373-105G4	121.11	42.57	1.47
parietal lobe - adult, donor10196	10171-103B9	102.51	42.32	0.00
parietal lobe, adult, donor10252	10157-103A4	107.74	40.48	0.57
parietal lobe, adult, pool1	10034-101E7	45.38	38.95	0.70
parietal lobe, fetal, donor1	10072-101I9	777.81	96.01	0.97
parietal lobe, newborn, donor10223	10356-105E5	158.52	59.44	1.12
parotid gland, adult	10199-103F1	513.06	103.60	3.08
penis, adult	10200-103F2	226.66	45.65	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	696.33	74.37	4.46
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	243.02	139.72	1.89
pineal gland - adult, donor10196	10179-103C8	88.37	48.38	0.00
pineal gland, adult, donor10252	10160-103A7	70.47	52.71	1.78
pineal gland, adult, donor10258	10377-105G8	218.85	63.33	1.25
pituitary gland - adult, donor10196	10180-103C9	225.63	80.94	1.01
pituitary gland, adult, donor10252	10162-103A9	144.37	85.47	0.00
pituitary gland, adult, donor10258	10378-105G9	597.57	95.34	2.55
placenta, adult, pool1	10021-101D3	91.38	37.20	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	558.97	230.95	4.24
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	108.01	30.04	0.00
pons, adult, pool1	10033-101E6	28.32	30.47	0.86
postcentral gyrus, adult, pool1	10032-101E5	54.57	46.29	0.96
promyelocytes/myelocytes PMC, donor1	12132-128D8	140.12	39.74	6.27
promyelocytes/myelocytes PMC, donor2	12136-128E3	1101.61	236.85	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	1830.78	234.72	0.00
prostate cancer cell line:DU145	10490-107B4	211.36	261.75	5.97
prostate cancer cell line:PC-3	10439-106E7	359.37	422.35	5.81
prostate, adult, pool1	10022-101D4	169.23	37.00	0.27
putamen, adult, donor10196	10176-103C5	107.17	60.20	0.94
putamen, adult, donor10252	10152-102I8	290.19	94.11	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	127.86	92.89	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	67.65	47.36	0.72
putamen, newborn, donor10223	10365-105F5	143.93	44.23	0.00
rectal cancer cell line:TT1TKB	10469-106I1	402.36	73.90	1.45
rectum, fetal, donor1	10067-101I4	606.47	75.11	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	163.87	95.82	1.48
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	122.61	31.89	0.00
retina, adult, pool1	10030-101E3	95.62	37.27	0.40
retinoblastoma cell line:Y79	10475-106I7	552.86	298.51	4.94
rhabdomyosarcoma cell line:KYM-1	10787-110H4	252.90	209.63	7.01
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	375.40	190.65	2.53
sacrococcigeal teratoma cell line:HTST	10695-109G2	469.87	83.36	0.76
salivary acinar cells, donor1	11771-123I7	372.27	83.68	1.62
salivary acinar cells, donor2	11772-123I8	571.54	56.59	0.96
salivary acinar cells, donor3	11773-123I9	475.35	45.68	3.31
salivary gland, adult, pool1	10093-102C3	501.60	78.93	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	175.79	83.97	1.77
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	201.01	100.15	1.29
seminal vesicle, adult	10201-103F3	204.22	79.36	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	207.21	80.89	1.70
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	371.41	160.04	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	448.58	376.32	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	194.09	29.82	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	150.43	62.12	2.21
signet ring carcinoma cell line:NUGC-4	10483-107A6	234.57	117.93	6.84
skeletal muscle - soleus muscle, donor1	10282-104F3	234.08	56.75	2.84
skeletal muscle, adult, pool1	10023-101D5	155.92	71.72	0.84
skeletal muscle, fetal, donor1	10066-101I3	1014.06	115.58	0.00
skin, adult, donor1	10074-102A2	271.41	47.50	0.00
skin, fetal, donor1	10065-101I2	329.50	118.67	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	266.48	347.86	5.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	506.53	111.90	7.25
small cell lung carcinoma cell line:DMS 144	10841-111E4	332.30	157.47	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	265.70	149.17	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	411.29	127.88	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	124.87	78.23	3.27
small intestine, adult, pool1	10024-101D6	115.14	38.82	0.96
small intestine, fetal, donor1	10064-101I1	229.73	55.53	0.49
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	219.52	34.36	4.10
smooth muscle, adult, pool1	10048-101G3	163.86	34.63	0.26
somatostatinoma cell line:QGP-1	10781-110G7	334.22	78.80	3.75
spinal cord - adult, donor10196	10181-103D1	136.50	65.61	0.92
spinal cord, adult, donor10252	10159-103A6	68.21	32.33	0.00
spinal cord, adult, donor10258	10369-105F9	228.29	51.19	0.69
spinal cord, fetal, donor1	10056-101H2	159.17	118.92	3.66
spinal cord, newborn, donor10223	10359-105E8	122.15	57.86	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	170.86	82.59	1.49
spleen, adult, pool1	10025-101D7	138.66	54.52	1.76
spleen, fetal, pool1	10044-101F8	114.81	43.38	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	367.37	155.06	3.73
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	255.38	111.46	2.28
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	127.20	61.85	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	1005.87	285.38	10.56
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	127.19	97.14	2.03
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	547.72	316.43	2.97
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	164.57	118.88	1.27
stomach, fetal, donor1	10062-101H8	309.71	71.55	1.07
submaxillary gland, adult	10202-103F4	439.22	99.12	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	94.30	39.46	0.00
substantia nigra, adult, donor10258	10371-105G2	115.35	55.86	1.03
substantia nigra, newborn, donor10223	10358-105E7	184.42	55.11	1.41
synovial sarcoma cell line:HS-SY-II	10441-106E9	278.79	187.77	11.00
temporal lobe, adult, pool1	10031-101E4	66.21	51.46	0.76
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	386.05	113.25	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	435.58	92.74	2.20
tenocyte, donor1	11763-123H8	231.45	102.98	1.05
tenocyte, donor2	11765-123I1	252.18	58.75	1.14
tenocyte, donor3	11768-123I4	263.54	117.87	2.22
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	233.36	216.87	4.76
teratocarcinoma cell line:NCR-G1	10798-110I6	315.54	221.51	4.62
teratocarcinoma cell line:PA-1	10807-111A6	270.75	175.74	1.86
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	327.14	235.87	8.51
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	347.54	97.19	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	564.73	133.71	2.29
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	280.10	128.65	3.58
testis, adult, pool1	10026-101D8	91.16	46.60	1.18
testis, adult, pool2	10096-102C6	221.48	102.85	1.35
thalamus - adult, donor10196	10168-103B6	149.04	41.95	0.00
thalamus, adult, donor10252	10154-103A1	98.93	40.95	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	81.60	36.95	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	69.33	42.98	0.99
thalamus, newborn, donor10223	10366-105F6	112.19	54.66	0.58
throat, adult	10209-103G2	204.48	74.40	1.25
throat, fetal, donor1	10061-101H7	252.30	67.04	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	539.76	227.55	5.37
thymus, adult, pool1	10027-101D9	118.01	40.66	0.70
thymus, fetal, pool1	10043-101F7	93.10	32.83	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	237.07	131.37	5.05
thyroid carcinoma cell line:TCO-1	10783-110G9	314.30	207.02	2.10
thyroid, adult, pool1	10028-101E1	117.11	50.67	1.31
thyroid, fetal, donor1	10060-101H6	127.88	64.07	1.05
tongue epidermis (fungiform papillae), donor1	10288-104F9	264.85	58.51	3.08
tongue, adult	10203-103F5	245.60	104.89	2.56
tongue, fetal, donor1	10059-101H5	260.10	94.98	1.58
tonsil, adult, pool1	10047-101G2	177.81	71.83	1.80
trachea, adult, pool1	10029-101E2	129.73	55.38	1.55
trachea, fetal, donor1	10058-101H4	225.82	106.56	3.46
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	254.02	175.72	6.38
transitional-cell carcinoma cell line:5637	10418-106C4	149.85	92.70	1.72
transitional-cell carcinoma cell line:JMSU1	10492-107B6	384.98	210.27	2.04
tridermal teratoma cell line:HGRT	10694-109G1	268.26	110.35	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	261.57	69.58	1.95
umbilical cord, fetal, donor1	10057-101H3	127.28	62.60	0.00
uterus, adult, pool1	10100-102D1	306.11	48.80	1.19
uterus, fetal, donor1	10055-101H1	318.93	95.73	1.54
vagina, adult	10204-103F6	296.61	52.34	0.00
vein, adult	10191-103E2	306.22	58.53	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	515.92	145.80	2.14